INTRODUCTION
Malignant mononuclear leukocytes from human, as well as murine, myelomonocytic leukemia are proliferating cells, as evidenced by nuclear incorporation of tritiated thymidine and mitotic activity. These cells demonstrate some of the characteristics of mature, normal monocytes and macrophages, including adherence to a charged surface, phagocytosis, and the presence of surface receptors for IgG immunoglobulins (1) (2) (3) . We recently observed that mononuclear phagocytes from most patients with acute myelomonocytic leukemia and from some patients with lymphoma were defective in microbicidal assays. These cells were capable of ingesting bacteria but were defective in their ability to inhibit the replication of ingested organisms. The intracellular bacteria were protected from some extracellular antibiotics.
METHODS
Patients studied. 15 normal subjects, 15 patients with nonhematologic malignancy, 10 patients with acute myelomonocytic leukemia, one patient with chronic monocytic leukemia, and nine patients with non-Hodgkin's lymphoma were studied (Table I ). All patients were free of infection at the time of study. The cases with myelomonocytic leukemia comprised a spectrum that varied from predominantly myeloblastic disease (90%o myeloblasts and promyelocytes) to predominantly monoblastic proliferation (58% monoblasts). Six of these patients had received extensive chemotherapy prior to study; four patients had never been treated. The patient with "chronic" monocytic leukemia had a chronic disorder characterized by anemia, thrombocytopenia, hepatosplenomegaly, and 10,000-12,000/mm8 mononuclear cells of variable morphologic maturity in her circulation.
Bacterial growth. Bacteria grown overnight in trypticase soy broth were washed by centrifugation with saline or Zobell's solution (Listeria nionocytogenes, ref. 4 ) and suspended at a concentration of approximately 2 X 10' colonies/ml. 'lu ml of the suspension was inoculated into 0.9 ml of McCoy's medium containing 30% normal human AB serum (ABM) and incubated at 37'C for 60 min when greater than 50% of the bacteria were in DNA synthesis.
These log phase organisms were used for microbicidal assay.
Microbicidal assays. Leukocytes were isolated from heparinized peripheral blood (5) (7, 8) . In the latter system, 1 drop of heparinized blood was mixed with 1 drop of ABM on an eight-chambered sterile slide (Lab-Tek Products, Westmont, Ill.) and allowed to stand without agitation at 37°C in a humidified incubator. After 60 min, nonadherent cells were gently washed off with warm Hanks' solution, and 1 drop of ABM containing log phase bacteria was added. Incubation for 30 min at 37°C was allowed for phagocytosis before nonphagocytized bac- (2) . Immature mononuclear cells had the morphological characteristics described previously (3, 9) . For the purpose of this study all mononuclear cells that were glass adherent and phagocytic, regardless of the degree of morphologic differentiation, were grouped together. In general, undifferentiated blast cells were nonadherent.
Phagocytosis. Bacteria were added in great excess to cell monolayers (approximately 200 organisms/cell). After the washing procedure to remove nonphagocytized organisms, only rare extracellular bacteria were observed adherent to the glass slide. By light microscopy the majority of bacteria appeared to be intracellular, with less than 10% of organisms extracellular but adherent to leukocytes.
Because the [3H]thymidine labeling technique is critically dependent upon the ability to distinguish celladherent bacteria from bacteria that have been ingested, this point was examined extensively in initial studies previously reported (7, 8) . The following approaches were used: (a) Intracellular location of phagocytized bacteria was confirmed by electron microscopy, which demonstrated organisms within phagocytic vacuoles. (Table   II) .
The mononuclear phagocytes of normal subjects, patients with acute myelomonocytic leukemia, lymphosar-.coma, and one patient with reticulum cell sarcoma appeared to be comparable in their ability to phagocytize the species of bacteria tested (Table II) . There was, however, considerable heterogeneity in the malignant leukocyte population, and miiany leukemic mononuclear cells had bacteria adherent to their surface but were not phagocytic. A similar heterogeneity was not seen among normal monocytes.
Inhibition of bacterial replication; bacterial kiUing. The mononuclear phagocytes of the patient with chronic monocytic leukemia were normal in their ability to inhibit all three of the organisms tested.
Of the nine patients with lymphoma, six with lymphosarcoma and one with reticulum cell sarcoma were entirely normal in the bacterial labeling studies. Monocytes from one patient with reticulum cell sarcoma receiving chemotherapy were abnormal when tested against Staph. aureus but normiial when tested against L. meonocytogenes (Table IV) . MIonocytes from another patient with lymphosarcoma were abnormal when tested against Staph. aureus, Escherichia coli, and Proteus vulgaris (Table IV) . She also had defective neutrophil function. Her abnormality persisted over the course of 1 mo when she was receiving vincristine as her sole therapy. She ultimately died of fulminant gram-negative bacterial sepsis.
Of the 37 microbial inhibitory tests of monocytes from patients with nonhematologic cancer, only one was outside the normal range. Seventeen of these tests were on patients receiving chemotherapy at the time of study.
It was concluded that malignancy or cytotoxic drug therapy per se was not a cause of an abnormal leukocyte functional test.
In the standard bacterial killing assay based on viable colony counts (6) , the neutrophil is the principal phagocyte and often obscures the microbicidal contribution of other phagocytic cells (10) . One of our patients (no. 10, Table IV) with myelomonocytic leukemia had no circulating neutrophils and sufficient phagocytic mononuclear cells to perform a standard killing assay with Staph. aureus 502A. Her mononuclear cells killed 10 and 60% of phagocytized bacteria at 30 and 60 min, respectively. These values are lower than those reported for normal monocytes (11, 12 (Table V) . When such organisms are phagocytized by defective mononuclear cells, they appear to be protected from the bactericidal action of the antibiotics. For example, as shown in Table V (one experiment of three), mononuclear phagocytes from a patient with myelomonocytic leukemia were defective in their ability to kill bacteria. Addition of antibiotics to the culture medium inhibited extracellular bacteria but had no effect on replicating intracellular organisms. The ingested organisms were therefore protected by virtue of their intracellular residence.
DISCUSSION
Analysis of normal and malignant mononuclear cell differentiation in man and the mouse suggests the following maturational sequence: promonocyte-monocytetissue macrophage (13, 14) . In these species and probably in many mammalian species, receptors on the cell surface for IgG immunoglobulins are detectable in the earliest identifiable cells of the series (15) . Therefore, a mechanism exists for attachment and subsequent ingestion of opsonin-coated bacteria. Phagocytic capacity increases with progressive cellular maturation and is best expressed in the mature macrophage (13) . The bactericidal mechanisms of the mature mononuclear phagocytes are largely undefined; they appear to be at least in part dependent upon available oxygen (4) and independent of the enzyme, myeloperoxidase, which does not exist in the mature cell. In contrast, monocytes depend upon myeloperoxidase for killing at least some microbial species (16) .
From the results reported here, there appears to be a disparity between the development of the phagocytic process and the bacterial killing mechanism of the mononuclear phagocytes of some patients with acute myelomonocytic leukemia and lymphoma. In normal monocytes, phagocytic ability and capacity to inhibit intracellular replications are well balanced, and over 90% of the test organisms are inhibited or killed in a short time. In the defective malignant mononuclear cells, phagocytosis occurs but intracellular bacterial replication continues to a greater degree than that observed in normal mononuclear leukocytes.
The clinical implications of these findings are that pathogenic bacteria and opportunistic pathogens may be sequestered within the malignant mononuclear cell, but not killed. In this cellular sanctuary they may be protected from the effects of antibiotics. This phenomenon, as well as the paucity of normal granulocytes, may contribute to the frequency of microbial infections in acute leukemia of adults and may explain the antibiotic resistance of such infections despite in vitro antibiotic sensitivity of the infecting organism. Other factors contributing to the enhanced susceptibility to infection in acute leukemia include immunologic impairment associated with chemotherapy and decreased numbers of circulating neutrophils. Additionally, the small numbers of mature neutrophils may be defective in microbicidal activity. Several of the patients described in this report were found to have defect in neutrophil (8) , as well as mononuclear leukocyte, function. Together these abnormalities constitute significant impairment of host defense functions.
The observation that microorganisms may be protected from the microbicidal systems of serum and from the lethal effects of antibiotics as a consequence of residence in defective leukocytes is not unique to this report. Klebanoff (17) has recently summarized the evidence for the occurrence of such a phenomenon in patients with a variety of hereditary leukocyte defects.
In addition to the abnormalities of phagocyte function in certain hematologic malignancies reported here, defective monocyte microbial activity has also been described in chronic granulomatous disease (11, 12) , in children with chronic neutropenia (18) , and in myeloperoxidase deficiency (5, 16) .
The mechanism of this abnormal function in malignant hematologic disease is entirely obscure. Its elucidation must await better understanding of the microbicidal process in normal mononuclear leukocytes. The bactericidal mechanisms of mononuclear phagocytes may be different from those of neutrophils (19) , and discovery of additional syndromes of defective monocyte function may be anticipated.
